Per-Ola Freskgard is currently a vice Director and Expert Scientist in Neuroscience, Roche Innovation Center Basel, Pharma Research and Early Development (pRED) ROCHE. He has a Ph.D. in Biochemistry and a post-doctoral visiting associate at California Institute of Technology, Chemical Engineering. 20 years of experience in big pharma and small biotech companies. He has authored or co-authored more than 65 peer reviewed international journals and patent applications in the fields of protein engineering and evolution, DNA encoding of small molecules, thrombosis and haemostasis and neuroscience. Recent years have been focused on technologies to deliver biotherapeutics over the blood brain barrier using a versatile Brain Shuttle technology platform.
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October